Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,434 | 18,691 | -33,277 | -45,738 | -37,230 |
| Depreciation Amortization | N/A | N/A | 2,770 | 2,459 | 2,311 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 164 |
| Accounts receivable | N/A | N/A | -2,624 | -1,813 | 5,343 |
| Accounts payable and accrued liabilities | 2,238 | -2,245 | -4,208 | 7,049 | -4,354 |
| Other Working Capital | -193 | -3,149 | -33,370 | 30,525 | -16,377 |
| Other Operating Activity | 4,549 | -27,000 | 10,777 | -142 | 4,247 |
| Operating Cash Flow | $-10,840 | $-13,703 | $-59,932 | $-7,660 | $-45,896 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -1,041 | -949 | -2,726 |
| Purchase Of Investment | N/A | N/A | -48,395 | N/A | -41,499 |
| Sale Of Investment | N/A | N/A | 28,200 | N/A | 83,437 |
| Investing Cash Flow | $N/A | $N/A | $-21,236 | $-949 | $39,212 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 18,433 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 7,214 | 59,127 | 10,115 |
| Other Financing Activity | 68,656 | 5,000 | 0 | 0 | 0 |
| Financing Cash Flow | $87,089 | $5,000 | $7,214 | $59,127 | $10,115 |
| Exchange Rate Effect | 3 | N/A | -5,175 | -3,190 | 4,745 |
| Beginning Cash Position | 7,350 | 16,053 | 117,764 | 70,436 | 62,260 |
| End Cash Position | 83,602 | 7,350 | 38,635 | 117,764 | 70,436 |
| Net Cash Flow | $76,252 | $-8,703 | $-79,129 | $47,328 | $8,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,840 | -13,703 | -59,932 | -7,660 | -45,896 |
| Capital Expenditure | N/A | N/A | -1,041 | -949 | -2,726 |
| Free Cash Flow | -10,840 | -13,703 | -60,973 | -8,609 | -48,622 |